Share

Meet the CELLINK Team! First up: CEO/Co-Founder Erik Gatenholm

Hello I’m Erik Gatenholm, Co-Founder and CEO here at CELLINK. For the past 8 years I have been working with commercializing different technologies in the biotech industry. Last year I founded CELLINK to revolutionize the way that we conduct medical research worldwide. My vision and dream is to make an impact on the world of medicine and truly change the industry once and for all.

I have a great passion for helping people as well as for entrepreneurial activities. I burn for sales, marketing, management, and leadership. During my spare time I truly enjoy spending time with my fiancee as well as working out and producing music.

Tell us something about you that people would be surprised to know? I truly enjoy producing music and I spent most of my childhood in bands and producing music. About two years ago I got signed by a Dutch record label for a song a friend and I co-produced.

If you could shadow one CEO for a week, who would it be and why? Daniel Ek (Spotify) or Elon Musk (Tesla). I think it would give me a great insight into the challenges and the way things work once the business has reached a completely different stage. I would also love to hear their story and how they managed to make their companies so successful.

Let’s pretend you’re a super hero, what would be your super power and why? Superman! He’s the perfect combination of a true gentleman, unbeatable strength, and he wears a lot of blue!

More News:

FOR DOCTORS AND medical researchers repairing the human body, a 3D printer has become almost as valuable as an x-ray machine, microscope, or a sharp scalpel. Bioengineers are using 3D printers to make more durable hip and knee joints, prosthetic limbs and, recently, to produce living tissue attached to a scaffold of printed material. Researchers...

PRESS RELEASE Gothenburg, Sweden December 5th, 2018, 08:30 CET CELLINK and Prellis Biologics Inc. sign partnership to commercialize high-resolution holographic bioprinting technology for micro-printing. The partners will utilize their IP, expertise, and know-how to offer the first system enabling ultra-high resolution bioprinting of microstructures such as vascular networks or capillaries. The technology is an important...